Missing Medical Data Could Harm Patients
January 4th, 2012 |
4
Big clinical trials—to test new drugs or procedures—generate reams of important data about safety and efficacy. Only a fraction of that information sees the light of day, a publishing practice that could put patients at risk, according to a special report published this week in the British Medical Journal (BMJ). Even though scientific and medical [...]
Keep reading »
Second human embryonic stem cell trial cleared by FDA
An embryonic stem cell treatment for a rare inherited form of blindness was approved Monday for clinical trials. This is only the second human embryonic stem cell-based trial to be approved by the U.S. Food and Drug Administration (FDA)—the first started last month with a Geron Corp. trial that is assessing the use of such [...]
Keep reading »MS treatment has patients seeking surgery–but more testing is needed
April 16th, 2010 |
17
TORONTO—Like electrical wires, neurons are insulated. But in multiple sclerosis (MS), the insulation (called myelin) is stripped or worn down, slowing conduction along the axons—the wires of the nervous system. MS is widely considered to be an autoimmune disease, in which the myelin is attacked by the body’s own T cells. But Paulo Zamboni, director [...]
Keep reading »
See what we're tweeting about
